Government borrowing costs are rising rapidly around the world / Photo: Mehaniq/Shutterstock.com
News·
Yields on global government bonds have reached multi-year highs. What's going on?
In August, Stellantis faced a series of downward revisions to its forecasts from major investment banks / Photo: MikeDotta/Shutterstock.com
News·
A malfunction in the rearview cameras forced Stellantis to recall nearly 1 million cars worldwide
Photo: Evgenia Eliseeva / Andrei Doronichevs personal archive
Review·
"I Learned from My First 10 Checks": Andrei Doronichev's Rules for Investing in Startups
Hearings in the federal court in Oakland against Meta will begin on August 18 / Photo: ADRIAN3388 / Shutterstock
News·
Billion-Dollar Fines and the Transformation of Social Media: 5 Questions About the New Lawsuit Against Meta
News·
Morgan Stanley believes Amazon's stock could double. Should you buy it?
News·
From a Hyatt Heir to a Duty-Free Tycoon: The Wealthiest Families Reveal Their Stakes in SpaceX
News·
$65 Billion in Sales: Anthropic Increases Revenue Forecast Sevenfold Ahead of IPO
News·
Concerns over the Iran deal dragged U.S. stocks lower. Oil is trading above $90 again.
Stock Screener
Buy
Sell
Go to section
Guru Portfolios

Track the investments of top funds and market legends

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Go to section
Small Caps
Viking Therapeutics and Kailera Therapeutics have promising GLP-1 candidates, a Motley Fool analyst believes / Photo: Unsplash / Joachim Schnürle
Small Caps·
Motley Fool sees big risks and big upside in anti-obesity drugmakers Viking, Kailera
Small Caps·
AI security solutions provider SoundThinking sinks 25% on lowered 2026 guidance
Small Caps·
Small caps last week: Playboy's pivot, AbCellera trial win, GLP-1 boon for AirSculpt
Small Caps·
Morgan Stanley sees 80% upside for anti-smoking drugmaker Achieve Life Sciences
Small Caps·
How Needham's Small Cap Growth Fund is benefitting from the AI boom
Go to section

Investment and Finance News